EUVIMEDEUVIMED entdecken
Kohortenstudie

Intrapleural Bevacizumab Plus Cisplatin Versus Cisplatin Alone for Malignant Pleural Effusion in Advanced Non-Small Cell Lung Cancer: A Cohort Study

Xuan Li, Jiesheng Chu, Guanjun Xu, Jingzhong Fu, Ruiyang Li, Yu Shi

Journal of Visualized Experiments · 20.11.2026 · (237)

DOI: 10.3791/72329 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Visualized Experiments, online erschienen am 20.11.2026. Verfasst von Xuan Li und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Li, X., Chu, J., Xu, G., Fu, J., Li, R., & Shi, Y. (2026). Intrapleural Bevacizumab Plus Cisplatin Versus Cisplatin Alone for Malignant Pleural Effusion in Advanced Non-Small Cell Lung Cancer: A Cohort Study. Journal of Visualized Experiments. https://doi.org/10.3791/72329

Vancouver

Li X, Chu J, Xu G, Fu J, Li R, Shi Y. Intrapleural Bevacizumab Plus Cisplatin Versus Cisplatin Alone for Malignant Pleural Effusion in Advanced Non-Small Cell Lung Cancer: A Cohort Study. Journal of Visualized Experiments. 2026. doi:10.3791/72329

BibTeX
@article{Li2026,
  author = {Li, Xuan and Chu, Jiesheng and Xu, Guanjun and Fu, Jingzhong and Li, Ruiyang and Shi, Yu},
  title = {Intrapleural Bevacizumab Plus Cisplatin Versus Cisplatin Alone for Malignant Pleural Effusion in Advanced Non-Small Cell Lung Cancer: A Cohort Study},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  number = {237},
  doi = {10.3791/72329}
}
Kostenlos starten →